Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 598 of 6351
-
Brain zaps for schizophrenia? new trial tests deep brain stimulation
Disease control Recruiting nowThis is a prospective, randomized, interventional study designed to evaluate the efficacy and safety of SEEG-guided deep brain stimulation (DBS) for symptom improvement in patients with treatment-resistant schizophrenia. Using stereo-electroencephalography (SEEG) to record brain …
Sponsor: Ruijin Hospital • Aim: Disease control
Last updated Jun 28, 2026 00:00 UTC
-
New drug combo aims to boost stroke recovery
Disease control Recruiting nowThis randomized controlled trial aims to evaluate whether adjunctive tirofiban therapy combined with endovascular treatment (EVT) improves neurological outcomes in patients with acute large vessel occlusion due to large-artery atherosclerosis. Patients will be randomized to recei…
Sponsor: Beijing Anzhen Hospital • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
New shot could tame hay fever symptoms for good
Symptom relief Recruiting nowAllergic rhinitis (AR) is a non-infectious chronic inflammatory disease of the nasal mucosa mainly mediated by immunoglobulin E after exposure to allergens in atopic individuals. The typical symptoms of AR are paroxysmal sneezing, watery rhinorrhea, itching, and nasal congestion,…
Phase 3 • Sponsor: Genrix (Shanghai) Biopharmaceutical Co., Ltd. • Aim: Symptom relief
Last updated Jun 26, 2026 13:41 UTC
-
New pill aims to quiet Alzheimer's psychosis
Symptom relief Recruiting nowML-007C-MA-221 is a Phase 2, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of ML-007C-MA in male and female participants aged 55 to 90 years with hallucinations and delusions associated with Alzheimer's Disease Psychosis (ADP). The primar…
Phase 2 • Sponsor: MapLight Therapeutics • Aim: Symptom relief
Last updated Aug 29, 2026 00:00 UTC
-
Could a quick digital test and blood draw detect Alzheimer's years early?
Diagnosis Recruiting nowThe investigators propose a stepwise screening approach. The first step involves rapid digital pre-screening of cognitive function through three components: the SCD-9 questionnaire to capture subjective cognitive complaints, a digital cognitive assessment to evaluate objective pe…
Sponsor: Xuanwu Hospital, Beijing • Aim: Diagnosis
Last updated Jun 27, 2026 08:04 UTC
-
Can a phone app help prevent heart attacks? new study aims to find out
Disease control Recruiting nowDespite the availability of medications, many people around the world continue to live with long-term health problems like heart disease, stroke and diabetes. In Canada, heart disease is a leading cause of death. Managing these health issues can be done by changing diet and lifes…
Sponsor: University of Toronto • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC
-
Could chemo before surgery beat cancer better?
Disease control OngoingThis clinical trial aims to compare the effectiveness and safety of two treatment options for patients with high-risk upper tract urothelial carcinoma (UTUC). One group will receive neoadjuvant chemotherapy with gemcitabine and cisplatin followed by surgery (radical nephrouretere…
Phase 2 • Sponsor: Changhai Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Could an arthritis drug boost IVF success in endometriosis patients?
Disease control CompletedThis prospective study targets infertile women with endometriosis (EM) who have experienced a previously failed Intracytoplasmic Sperm Injection (ICSI) trial. Using the P-I-C-O framework, the study evaluates whether the administration of an anti-TNF-α therapy (Intervention) 4-5 d…
Phase 2 • Sponsor: Benha University • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC
-
Asthma drug may ease brain fog in gulf war illness
Disease control Recruiting nowThe study addresses the pre-clinical promise of Montelukast (MLK) for improving brain function in veterans with Gulf War Illness (GWI). MLK, a US Food and Drug administration (FDA)-approved drug for asthma, has shown efficacy in an animal model of GWI to improve cognitive and moo…
Phase 1 • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC
-
Friendly bacteria may fight off repeat joint infections
Prevention By invitation onlyProsthetic joint infection (PJI) is one of the most devastating complications following total joint arthroplasty (TJA) of the hip and knee. Standard of care (SOC) treatment includes surgery and antimicrobials. Morbidity and mortality remain high despite contemporary treatments. T…
Phase 4 • Sponsor: Boston Medical Center • Aim: Prevention
Last updated Aug 28, 2026 00:00 UTC
-
Could a common food fiber boost immunotherapy in kidney cancer?
Disease control Recruiting nowThis phase I/II trial tests the safety and effectiveness of inulin gel in combination with ipilimumab and nivolumab in treating patients with kidney cell cancer (renal cell carcinoma \[RCC\]) that has spread from where it first started (primary site) to other places in the body (…
Phase 1/2 • Sponsor: University of Michigan Rogel Cancer Center • Aim: Disease control
Last updated Aug 02, 2026 00:00 UTC
-
New trial tests if adding chemo to radiation boosts survival for head and neck cancer patients
Disease control Recruiting nowThe main objective of this trial was to determine the value of concurrent chemoradiotherapy for Intermediate-risk head and neck squamous cell carcinoma
Phase 3 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
New Pill-and-Shot combo aims to wipe out HER2+ breast cancer before surgery
Disease control Recruiting nowThe goal of this clinical trial is to evaluate the efficacy and safety of oral paclitaxel plus fixed-dose combination of pertuzumab and trastuzumab for subcutaneous injection in the neoadjuvant treatment of HER2+ breast cancer patients.
Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
Smartphone rehab for heart failure: a new hope for rural patients?
Disease control Recruiting nowThis study evaluates a mobile health (mHealth) home-based cardiac rehabilitation program for patients with heart failure. We will stratify randomization between rural and urban populations, with the goal to assess implementation of cardiac rehabilitation across these two geograph…
Phase 3 • Sponsor: University of Texas Southwestern Medical Center • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New MRI-Guided radiation aims to tame recurrent prostate cancer with fewer side effects
Disease control Recruiting nowThe purpose of this study is to assess the impact of prostate-specific membrane antigen/positron emission tomography (PSMA/PET)-informed magnetic resonance (MR)-guided radiation therapy on serious toxicity outcomes in patients with biopsy-proven locally radiorecurrent prostate ca…
Sponsor: NYU Langone Health • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
Eye test and blood markers could spot dangerous pregnancy condition earlier
Diagnosis CompletedHypertensive disorders of pregnancy (HPT) are an important cause of maternal-feto-neonatal morbidity and mortality, being one of the three leading causes of maternal death in our country and in developing countries. The only cure for THE is termination of pregnancy, which ends up…
Sponsor: Saint Thomas Hospital, Panama • Aim: Diagnosis
Last updated Jul 18, 2026 00:00 UTC
-
Can a targeted pill boost Chemotherapy's punch against a rare lymphoma?
Disease control Recruiting nowIn this study, the XNW5004 tablets combined with CHOP/CHOEP will be used for the treatment of newly diagnosed PTCL patients.
Phase 1/2 • Sponsor: Evopoint Biosciences Inc. • Aim: Disease control
Last updated Jul 31, 2026 00:00 UTC
-
Hands-On healing: could touch or reflexology soothe menopause and sleep woes?
Symptom relief CompletedThis randomized controlled trial was designed to compare the effects of therapeutic touch and reflexology on sleep quality and menopausal symptoms in postmenopausal women affected by the February 6, 2023 Kahramanmaraş earthquakes. The study included 155 postmenopausal women assi…
Sponsor: Osmaniye Korkut Ata University • Aim: Symptom relief
Last updated Aug 19, 2026 00:00 UTC
-
New cell therapy takes on hard-to-treat brain lymphoma in early trial
Disease control Recruiting nowThis study will test whether MB-CART19.1 is a safe and effective treatment for central nervous system lymphoma (CNSL). This study will test different doses of MB-CART19.1 to find the highest dose that causes few or mild side effects in participants.
Phase 1 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 13:03 UTC
-
Can a Clot-Buster help stroke patients on blood thinners?
Disease control Recruiting nowAn investigator-initiated, multicenter, randomized, placebo-controlled, double-blind trial to determine the efficacy and safety of intravenous tenecteplase thrombolysis in acute ischemic stroke (AIS) patients with recent direct oral anticoagulants (DOACs) intake in improving the …
Phase 3 • Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC